About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Houston | 499 Studies

Clinical Trials Ovarian CancerHouston

Ovarian Cancer Clinical Trials in Houston

Find 499 clinical trials for ovarian cancer near Houston, Texas. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 499 trials

TerminatedStudy of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesA first-in-human study using BDC-3042 as a single agent and in combination with cemiplimab in patients with advanced malignanciesNCT06052852·Palo Alto, California and 5 others Active not recruitingVeliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionThis phase I trial studies the side effects and the best dose of veliparib when given together with paclitaxel and carboplatin in treating patients with solid tumors that are…NCT01366144·Duarte, California and 16 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection.NCT05334069·Anchorage, Alaska and 744 others

Active not recruitingTesting the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal CancerThis phase II trial studies how well olaparib with or without tremelimumab works in treating patients with ovarian, fallopian tube, or peritoneal cancer that has come back…NCT04034927·Orange, California and 19 others

CompletedPharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsProspective, open-label, dose-ranging, uncontrolled phase I/II study of Lurbinectedin in combination with irinotecan.NCT02611024·Santa Monica, California and 22 others

CompletedEvaluation of Robot-Assisted Surgery in Gynecologic OncologyThe goal of this observational study is to collect information about the length of surgery, the procedures performed during surgery, and any possible side effects of…NCT00671827·Gilbert, Arizona and 1 other

CompletedA Study of ZYC300 Administered With Cyclophosphamide Pre-DosingThe purpose of this study is to evaluate the feasibility, safety, and tolerability of administering ZYC300 with Cyclophosphamide (Cytoxan).NCT00381173·Boston, Massachusetts and 1 other

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

RecruitingFT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid TumorsThis is a Phase 1 study of FT836 administered in participants with advanced solid tumors.NCT07216105·La Jolla, California and 4 others

CompletedA Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)The Purpose of this study is to investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of hSTC810 monotherapy in participants with advanced solid tumors.NCT05231746·New Haven, Connecticut and 4 others

RecruitingFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsStudy STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of STX-478…NCT05768139·Los Angeles, California and 64 others

CompletedHormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal CancerRATIONALE: Estrogen can stimulate the growth of ovarian cancer cells.NCT00003670·Columbia, Missouri and 3 others

TerminatedPhase 1/2a Study of SQ3370 in Patients With Advanced Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors.NCT04106492·Duarte, California and 9 others

UnknownIntraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian OriginThe goal of this clinical research study is to learn about the safety and tolerability of paclitaxel and carboplatin when given in combination with Avastin to patients with…NCT00652119·Baltimore, Maryland and 4 others

RecruitingA Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian CancerThe goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and also to find the optimal dose of OPB-101.NCT07030907·Detroit, Michigan and 3 others

CompletedPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of intravenous (IV) administration of XmAb808 in combination with pembrolizumab in subjects…NCT05585034·Los Angeles, California and 11 others

TerminatedStudy of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)This is a Phase 1, open-label, dose-escalation and expansion study evaluating the safety, tolerability, PK, antitumor activity, and effect on biomarkers of XL102 administered…NCT04726332·Atlanta, Georgia and 4 others

CompletedESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid TumorsIn DESTINY-Pan-Tumor \[DP-02\], DESTINY CRC02 \[DC-02\], and DESTINY-Lung01 \[DL-01\], T-DXd demonstrated tumor response across a broad range of HER2-expressing solid tumors…NCT06973161·Spartanburg, South Carolina and 26 others

CompletedDasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerThis pilot phase I trial studies how well dasatinib works together with paclitaxel and carboplatin in treating patients with stage III, stage IV, or endometrial cancer that has…NCT01440998·Houston, Texas

CompletedFirst-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express MesothelinThe purpose of this study is to evaluate, in patients with tumors known to express the protein mesothelin, the following properties of BAY2287411 injection: * safety (to…NCT03507452·Bethesda, Maryland and 6 others

PreviousPage 7 of 25Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia